i ED 3 ED 3 ED ED 17 ED 17

Size: px

Start display at page:

Download "i ED 3 ED 3 ED ED 17 ED 17"

溆复傅
7 years ago
Views:

1 MMPs B

2 i ED 3 ED 3 ED ED 17 ED 17

3 CIEF MMPs MMPs 34 MMP 34 MMP 35 MMP 36 MMP 38 MMP ii

4 50 MMP 50 MMP 50 MMP MMP 51 MMP 51 MMP iii

5 (Erectile Dysfunction, ED), ED 2226 CIEF ED 28.33% % ED 14.84% 6.58% 4.95% ED CIEF-5 ED 1

6 Abstract Male Erectile Function Study in 3 Chinese Cities Objective: Erectile dysfunction (ED) is one of the most common sexual disorders in aging male. It is still difficult to estimate accurately the prevalence of ED worldwide. Through this investigation, we want to determine the prevalence of Erectile dysfunction (ED) and its relative factors in China. Materials and methods: A structured questionnaire (including CIEF-5) was administered by trained interviewers. There were 2226 subjects collected from Beijing, Chongqing and Guangzhou. Results: The prevalence of ED was 28.3%(total group), and 40.2%( 40yrs group). The prevalence of mild, moderate and severe ED was 14.84%, 6.58% and 4.95%, respectively. Conclusion: Besides ageing, several medical condition such as cardiovascular disease, diabetes, hyperlipidemia were correlated with the prevalence of ED. Psychological and environmental factors such as couple relationship and living condition, are also very important to the development of ED. Lifestyle factor such as cigarette smoking, maybe another concomitant risk factor. Keywords: erectile dysfunction(ed); epidemiology; aging 2

7 ED ED [1] ED ED ED ED ED ED ED ED ED 1948 ED ED ED [2] 1992 NIH ED [3] ED 1994 Massachusetts Male Aging Study, MMAS [4] ED ED 3

8 ED ED ED 10 ED ED ED 1 1. ED / / ED Feldman et al [4] % 1997 [5] % % % % Sato et al [6] % % % % 4

9 Pfizer Cross-National Study,1998 [7] Moreira,2001 [8] Morillo,2001 [9] 81.1% 69.8% 62.1% 39.9% % % ED ED [10] [11] ED ED [12] ED ED Kinsey 1948 ED ED [2] 1994 MMAS ED [4] ED [6] IIEF 5

10 [13] ED [5] ED ED ED ED 60 ED [14] ED ED ED % 7% 8% [15] ED ED 50-75% ED 23 9 [16] 50 IIEF

11 [13] ED II [17] MMAS ED 3 ED [4] 10 ED 50% ED ED 7 ED [18] ED 6 [19] MMAS 24 Cooper 12 [20] ED ED MI [13] 60 ED 59 MMAS 35 [21] ED 39 ED [4] ED [14] ED 7

12 ED MMAS ED ED [22] ED ED [23-26] ED 45 [27] Leydig 1975 ED ED 50 [28] Cerqueira 58 ED [29] ED CI ED 45 CI ED 63 CI CI [30] ED 41.5% [31] 3 [32] ED ED [33] 50 ED 70 8

13 25 ED [34] ED ED [35] MMAS ED 28 [42] ED [36-41] ED ED ED [43-45] ED [46] ED ED [47] ED 30 2 [26,48] ED [26,46,47] ED [49] LH / ATP ED [50] 9

14 ED [51] LHRH ED [37] ED LHRH ED ED [52] [53] ED [38] ED ED ED ED 178 ED [54] ED 4462 ED ED P [55] MMAS ED 2 24%vs14% ED [22] MMAS ED 10

15 ED [4] 20% 8.5% 9.4% [4] ED 14% 41% 7.5% 21% 21% 52% [56] Mirone ED ED ED ED [57] 50 ED P<0.05 [58] [59] ED ED [60] HDL 60mg/dl 1.55mmol/L ED 30 mg/dl 0.78mmol/L 0.3 TC 240mg/dl 6.2mmol/L 180mg/dl 4.65mmol/L ED 1.83 [60] MMAS HDL ED [4] 11

16 [14,61,62] ED Johannes ED CI ED Ansong [63,64] ED [65] [66] ED 23 vs56 ED [67] ED [68] 50 [69] ED [70] ED [71] 12

10389144 2006 5 30 2006 5 30

10389144 10389144 2006 5 30 2006 5 30 ED ED IIEFEFOF SDISOS ED 10 2 2 1 10 4 1 1 4 4 IIEF SD EFOFISOS EF 2 1 1 4 1 ED ED Study on the effect of Sex Therapy for Erectile Dysfunction Patients ABSTRACT Objective